Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS Medicare Rx Price Negotiations Would Fail For Lack Of Force, CMS Says

This article was originally published in The Pink Sheet Daily

Executive Summary

The current Administration, as well as those in the future, would not be willing or able to enforce drug prices significantly below competitive market rates, CMS Chief Actuary Foster says in memo. Giving HHS price negotiating authority would lead to restrictions on drug choice, Administrator McClellan asserts.
Advertisement

Related Content

HDMA Monitoring Efforts To Repeal Medicare "Non-Interference" Clause
HDMA Monitoring Efforts To Repeal Medicare "Non-Interference" Clause
HHS Negotiating Authority Should Be Medicare Law's Only Change – Kennedy
HHS Negotiating Authority Should Be Medicare Law's Only Change – Kennedy

Topics

Advertisement
UsernamePublicRestriction

Register

PS061565

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel